While these drugs offer important treatments for obesity and diabetes, conditions that disproportionately impact Black Americans and underserved populations, their potential is undermined by systemic barriers that prioritize profits over public health
"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026
Other Weight Management Medications in Obese and Overweight Patients
For these patients, the combination approach discussed earlier is more appropriate than a complete switch
Cardio is zinvol, maar krachttraining verdient prioriteit Wandelen, fietsen, zwemmen of andere vormen van cardio zijn absoluut waardevol voor je conditie, hartgezondheid en algemene energieverbruik